Learn about Prasol Chemicals Limited’s Draft Red Herring Prospectus filing, business operations, financial context, and the proposed utilisation of funds as outlined in public disclosures.
Prasol Chemicals Limited, a key player in the specialty chemicals sector, has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI). This marks the beginning of its journey towards raising capital via an initial public offering (IPO). The DRHP outlines the company’s business profile, operational highlights, financial performance, and the proposed structure of the IPO, which aims to raise significant funds for further expansion.
Prasol Chemicals Limited submitted its Draft Red Herring Prospectus (DRHP) to SEBI on 14 October 2025. The DRHP is currently under regulatory review, and Prasol Chemicals awaits SEBI’s observations before proceeding to the next steps. These steps include the filing of the Red Herring Prospectus (RHP), announcement of the price band, and the finalisation of the IPO dates.
Once approved by SEBI, Prasol Chemicals intends to list its equity shares on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). The exact issue size will be disclosed in the RHP, with details about the offering price to be determined based on market demand.
As per the DRHP, the proposed IPO is structured as follows:
| Particulars | Details |
|---|---|
Issue Type |
Fresh Issue of Equity Shares |
Offer for Sale |
Yes, by selling shareholders |
Face Value |
₹2 per equity share |
Issue Size |
Fresh issue of up to ₹80 crore and Offer for Sale of up to ₹420 crore (Total up to ₹500 crore) |
Proposed Listing |
NSE and BSE |
Price Band |
To be announced in RHP |
Book Running Lead Manager |
DAM Capital Advisors Ltd. |
Registrar to the Issue |
KFin Technologies Ltd. |
These details reflect the early-stage disclosures available in the DRHP. The figures and terms are subject to change based on SEBI’s observations and regulatory approvals.
Prasol Chemicals Limited is a prominent player in the specialty chemicals industry, known for its high-quality products used in various industrial applications. The company operates primarily in the manufacturing of high-performance chemicals and intermediates, catering to industries such as agrochemicals, pharmaceuticals, and paints & coatings. Prasol Chemicals has a strong manufacturing base and is known for its innovative research and development efforts.
The company's manufacturing facilities, located in Maharashtra, India, are equipped with advanced technology to support the efficient production of specialty chemical products. The company’s operations include product development, manufacturing, marketing, and sales.
The funds raised through the IPO are planned to be used for the following objectives:
| Purpose | Details |
|---|---|
Repayment of Borrowings |
Repayment/prepayment of certain existing borrowings of the company |
Working Capital Requirements |
Funding the company’s working capital needs |
General Corporate Purposes |
Supporting operational, strategic and general business needs |
The net proceeds are proposed to be used for repayment of borrowings, working capital requirements, and general corporate purposes.
Prasol Chemicals Limited’s financial performance, as outlined in the DRHP, reflects a consistent growth pattern, underpinned by strong operational efficiency and market demand for its specialty chemicals.
| Fiscal Year / Period | Revenue from Operations (₹ Crores) | Profit / (Loss) After Tax (₹ Crores) | Net Worth (₹ Crores) |
|---|---|---|---|
FY23 |
~ 930.08 |
~ 48.59 |
Not explicitly disclosed in publicly reported sources |
FY24 |
~ 876.56 |
~ 18.13 |
Not explicitly disclosed in publicly reported sources |
FY25 |
~ 1012.49 |
~ 43.56 |
Not explicitly disclosed in publicly reported sources |
*The complete financial details, including audited figures, are available in the DRHP for those seeking a detailed understanding of Prasol Chemicals’ financial health.
The following table summarises the current status of the IPO process based on publicly available information:
| Milestone / Stage | Date (or Status) | Details |
|---|---|---|
DRHP filed with SEBI |
14-Oct-25 |
Draft Red Herring Prospectus submitted for regulatory review |
SEBI observations |
Awaited |
Subject to SEBI review |
RHP filing |
To be filed |
Post SEBI observations |
IPO Opening Date |
To be announced |
Final dates to be disclosed in the RHP |
IPO Closing Date |
To be announced |
As per RHP |
Allotment Date |
To be announced |
Post IPO closure |
Credit to DEMAT Accounts |
To be announced |
After allotment |
Listing on NSE/BSE |
To be announced |
Subject to completion of IPO process |
Note: Investors should refer to official filings for final IPO dates to learn more about Parasol Chemicals IPO listing details and price, and listing timelines.
Check other upcoming IPO’s here: Upcoming IPO
This content is for informational purposes only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Prasol Chemicals Limited filed its Draft Red Herring Prospectus with SEBI on 14 October 2025, initiating the regulatory process for its proposed initial public offering (IPO).
The Prasol Chemicals IPO is currently at the Draft Red Herring Prospectus review stage. The company awaits SEBI’s observations before progressing to the filing of the Red Herring Prospectus (RHP) and finalising the IPO subscription dates.
The Prasol Chemicals IPO includes a fresh issue of equity shares and an offer for sale by the existing shareholders. The fresh issue is expected to raise up to ₹800 million, while the offer for sale by selling shareholders will raise up to ₹4,200 million.
Subject to regulatory approvals, Prasol Chemicals Limited intends to list its equity shares on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
The funds raised from the IPO will be used for construction and project development, repayment of borrowings, land acquisition for future expansion, and other general corporate purposes.